NASDAQ$PAYS

Paysign Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Reported strong third-quarter results with revenue growth and increased adjusted EBITDA.

Paysign reported a strong third quarter with a 23.0% increase in revenue and a 20.6% increase in adjusted EBITDA. The growth was driven by a 219.1% year-over-year increase in revenue from patient affordability programs and an improvement in gross margins.

  • Revenue increased by 23.0% year-over-year.
  • Adjusted EBITDA increased by 20.6% year-over-year.
  • Revenue from patient affordability programs increased by 219.1% year-over-year.
  • Gross margins improved by 440 basis points to 55.5% compared to the third quarter of 2023.

Headline financials

Total Revenue

$15.3M

Previous: $12.4M+23.0%
EPS

$0.03

Previous: $0.02+50.0%
Avg. Revenue/Plasma Ctr

$7.99K

No prior period
Plasma Centers

478

No prior period
Active Affordability Programs

66

No prior period
Gross Profit Margin

55.5%

No prior period
Capital Expenditures

-$318K

Previous: -$218K-45.9%
Free Cash Flow

$1.12M

Previous: $882K+26.8%
Net Income

$1.44M

Previous: $1.1M+30.5%
Operating Income

$690K

Previous: $590K+16.8%
Gross Profit

$8.47M

Previous: $6.33M+33.8%
Stock-Based Comp

$573K

Previous: $710K-19.2%

Revenue & EPS history

Paysign · Revenue · Quarterly

$15.3M

Q3 2024+23%vs Q3 2023
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Forward guidance

Paysign expects total revenues to be in the range of $56.5 million to $58.5 million, and adjusted EBITDA to be in the range of $9.0 million to $10.0 million (15.0% to 17.0% of total revenues), or $0.16 to $0.18 per fully diluted share.

Tailwinds

  • Total revenues are expected to be in the range of $56.5 million to $58.5 million.
  • Adjusted EBITDA is expected to be in the range of $9.0 million to $10.0 million.
  • Adjusted EBITDA is expected to be 15.0% to 17.0% of total revenues.
  • Adjusted EBITDA per fully diluted share is expected to be $0.16 to $0.18.
  • Operating results are anticipated to be within the provided ranges despite a one-time expense related to legal fees.

Headwinds

  • Legal fees related to the settlement of class action and derivative lawsuits are expected to be expensed during the fourth quarter.
  • The legal fees expense was not anticipated at the time financial guidance was provided.
  • Headwinds in the plasma business related to difficult weather conditions.
  • Headwinds in the plasma business related to employment conditions.
  • Headwinds in the plasma business related to a slowdown in spending by cardholders.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+16.2%

Avg return

Earnings day

+4.1%

Avg return

5 days after

+7.8%

Avg return

30 days after

44%

27 / 61 earnings

Positive

+900.0%

Q3 2011

Best reaction

-29.6%

Q4 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+37.3%-4.3%
Q1 2026-12.6%-12.0%+4.8%
Q3 2025+0.2%-8.8%+0.4%
Q2 2025+13.0%+4.2%+0.6%
Q1 2025+3.0%+22.9%+81.9%
Q4 2024-8.5%-14.5%-8.1%
Q3 2024+10.9%+8.7%-7.9%
Q2 2024-6.7%-14.4%-9.2%
Q1 2024-0.4%+5.4%-7.6%
Q4 2023+20.5%+10.2%+31.9%
Q3 2023+18.1%+21.6%+18.1%
Q2 2023+6.4%+8.6%+16.0%
Q1 2023-1.8%-4.5%-20.7%
Q4 2022+4.2%+7.6%+0.3%
Q3 2022-10.4%+8.9%+16.5%
Q2 2022+7.4%+15.3%+33.5%
Q1 2022-26.2%-20.2%-2.4%
Q4 2021-6.6%-16.6%-21.4%
Q3 2021-9.0%-14.6%-32.8%
Q2 2021-2.4%+5.6%+16.7%
Q1 2021-11.4%-10.8%+0.0%
Q4 2020+11.7%+5.1%+0.8%
Q3 2020-26.8%-20.6%-7.7%
Q2 2020-18.9%-30.5%-45.3%
Q1 2020-5.5%-13.0%-0.4%
Q4 2019+27.3%+82.9%+102.7%
Q3 2019+13.2%+17.1%+3.9%
Q2 2019+2.5%+6.3%+2.7%
Q1 2019-11.7%-6.7%+18.2%
Q4 2018-1.7%-7.5%-1.0%
Q3 2018-0.5%-1.6%-6.3%
Q2 2018+10.1%+2.7%-2.7%
Q1 2018-0.9%+18.8%+23.1%
Q4 2017+19.0%+20.6%+44.3%
Q3 2017+7.9%+19.3%+15.8%
Q2 2017+2.8%+9.4%+0.0%
Q1 2017-8.7%-6.5%-6.5%
Q4 2016+4.7%+0.0%+0.0%
Q3 2016+34.9%+73.7%+73.7%
Q2 2016+0.0%-5.0%-20.0%
Q1 2016-23.2%
Q4 2015-29.6%
Q3 2015-12.0%
Q2 2015+6.3%
Q1 2015+4.3%
Q4 2014+71.2%
Q2 2014-16.7%
Q1 2014+0.0%
Q4 2013+23.4%
Q3 2013-17.9%
Q2 2013-16.6%
Q4 2012-4.3%
Q1 2013-4.3%
Q3 2012+18.5%
Q2 2012+0.0%
Q1 2012+0.0%
Q4 2011+0.0%
Q3 2011+900.0%
Q2 2011+0.0%
Q1 2011+0.0%
Q4 2010+5.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro